NPPC Supports Livestock Provisions Of Heroes Act

May 15, 2020

The National Pork Producers Council (NPPC) expressed strong support for livestock agriculture provisions in the Heroes Act introduced today by the U.S. House of Representatives Committee on Appropriations. These provisions include funding for the U.S. Department of Agriculture to provide:

Compensation for euthanized livestock that can’t be processed into the food supply due to COVID-related packing plant capacity reductions. This fact sheet provides an overview of the current challenge faced by U.S. pork producers.
Expanded direct payments to livestock farmers who have suffered severe losses as COVID-related market disruptions have caused the value of their livestock to plummet. In USDA implementation of this program, NPPC continues to seek the removal of payment caps to ensure much-needed aid is extended to those farmers who need it most.
Increased funding for animal health surveillance and laboratories, which have been tapped to perform COVID-19 testing during this human health emergency.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.